Search for Clinical Trial Results

Sponsored By

Hepatitis B, Chronic - 28 Studies Found

Status Study
No longer available Study Name: Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Date: 2014-12-23
Interventions: Drug: Emtricitabine emtricitabine were given to each patients for 48 weeks
Completed Study Name: Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
Condition: Hepatitis B, Chronic
Date: 2011-11-17
Interventions: Drug: GSK548470 300 mg tablet Blue tablets containing 300 mg of tenofovir disoproxil fumarate
Completed Study Name: Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Date: 2014-02-27
Interventions: Drug: Adefovir dipivoxil or Entecavir Adefovir tablet, 10m
Completed Study Name: Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Date: 2009-06-15
Interventions:
  • Drug: Entecavir and peginterferon alfa-2a

Completed Study Name: Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Date: 2009-06-08
Interventions:
  • Drug: Entecavir and peginterferon (Pegasys) (52 weeks)

Completed Study Name: Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Date: 2011-03-08
Interventions: Drug: Peginterferon alfa-2a Peginterferon alfa-2a at 180 ug weekly for 24 weeks
Completed Study Name: Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
Condition: Hepatitis B, Chronic
Date: 2006-11-01
Interventions: Drug: entecavir Tablets, Oral, 1 mg, once daily, up to 72 weeks
Completed Study Name: Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue
Condition: Hepatitis B, Chronic
Date: 2011-11-23
Interventions:
  • Drug: GSK548470 300 mg tablet

Not yet recruiting Study Name: Emtricitabine for Naive Chinese Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Date: 2014-12-23
Interventions: Drug: Emtricitabine emtricitabine were given to each patients at baseline and respoonse guided therapy w
Completed Study Name: Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Date: 2008-03-26
Interventions: Drug: Telbivudine 600 mg/day, oral telbivudine for 52 weeks
Next >>>